COVID-19

General Information

NCTTRAC is working closely with the Texas Department of State Health Services (DSHS) and with regional hospitals, EMS agencies, public health agencies, and emergency management to help coordinate the ESF-8 response to COVID-19 in Trauma Service Area E. You can view the current case counts in Texas by visiting the DSHS News Update webpage.

COVID-19 Infusion Centers

As of April 2021, the Regional Infusion Sites under MPP’s contract is no longer active. NCTTRAC, TDEM, and MPP Infusion partnered to create two Regional Infusion Centers to administer COVID-19 monoclonal antibodies to outpatients referred from area physicians, clinics, urgent care centers, and hospitals in January 2021.  These facilities was funded by TDEM and are operated by MPP Infusion.  Infusions are still available, you can locate the nearest facility through Texas COVID-19 Therapeutics Availability Map. 

Below you’ll find a few informational links about the specific treatments as well as the Texas COVID-19 Therapeutics Availability Map. 

Clickable Links

Texas COVID-19 Therapeutics Availability
Information about Regeneron Cocktail (Casirivimab and Imdevimab)
Information about Bamlanivimab

Other Infusion-Related Information

Long-Term Care facilities can request monoclonal antibody infusions at their facility directly from the state; click here for more information.

Covid-19 Test Kits and Turbo-UV Sanitizer Requests

Contact the EMCC

817-608-0390 – Main EMCC Number
817-607-7020 – 24/7 TSA-E Emergency Phone
NCTTRAC_EMCC@ncttrac.org

documents

Public

TypeFile Name

pdf
Informacion De Centros De Infusiones Para Pacientes De COVID19

pdf
NCTTRAC PPE Distribution Ending May 17 Notice
X
X
PopUp